Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.
The research used multiple genetic analyses on samples collected over 29 years to show changes associated with disease progression.
The new division will enable BGI to expand partnerships with universities, companies, and health and agriculture-related organizations, among other things.
The study is the first published data of BGI's desktop sequencer, BGISEQ-500, which German researchers are studying for use in evaluating microRNA biomarkers.
The researchers reported that about three quarters of the 10-gigabase ginkgo genome consists of repeat sequences.
The new BGISEQ-50, a smaller version of the BGISEQ-500, will have research and clinical applications, and BGI plans to register it with the CFDA, too.
The partners are planning a joint research center at Providence Health Care's St. Paul's Hospital in Vancouver and a center of excellence in China.
Researchers established a high-quality version of the five-pacer viper genome and used it to take a wider look at snake relationships and adaptations.
The Shenzhen-based nonprofit research institute will be equipped with NGS instruments developed by BGI and will include a biorepository and bioinformatics center.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.